Prescription For Failure: Why Trump’s Drug Plan Is Bad w/ Yale Economist Jason Abaluck
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Prescription For Failure: Why Trump’s Drug Plan Is Bad w/ Yale Economist Jason Abaluck
-
Narrado por:
-
De:
Acerca de esta escucha
Send us a text
Two weeks after Donald Trump announced he was going to lower drug prices from anywhere from 30% to 90%, there still haven't been any deals made.
But more than that, what he wants to do, something called Most Favored Nation status, is bad policy, especially when it comes to drug prices.
Grant is joined by Yale Economist Jason Abaluck to talk about why Trump's plan to lower drug prices won't lower them, might raise prices, could stifle medical innovation at home and abroad, and what that means for your next prescription.
LINKS:
Jason Abaluck's Research
Support the show
Follow along on social media
X: @mimsnewspod
Instagram: @mimsnewspod
TikTok: @mimsnewspod
Substack: mimsnewspod.substack.com
YouTube: youtube.com/@MIMSnewspod
Bluesky: Granthermes.bsky.social
Follow Grant:
X: @GrantHermes
Insta/TikTok: GrantHermesTV